Skip to main content

Medical Treatments: Radioisotopes

Question for Department of Health and Social Care

UIN 48259, tabled on 13 September 2021

To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) support the rollout of nuclear medicines across the NHS and (b) prevent regional variations in access to those medicines.

This answer is the replacement for a previous holding answer.

Answered on

11 October 2021

Nuclear medicine is already used widely in the National Health Service in England to diagnose and treat a variety of diseases. NHS England and NHS Improvement routinely fund licensed medicines that have been recommended by the National Institute for Health and Care Excellence or off-label use of licensed medicines that have been approved via the NHS England clinical commissioning policy process.

NHS England and NHS Improvement commission positron emission tomography/computed tomography scan while other diagnostic imaging involving nuclear medicine is commissioned by clinical commissioning groups (CCGs). It is for CCGs to commission those services according to the needs of their local population.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.